{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:31:39Z","timestamp":1790299899712,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100003928","name":"Lungs for Life Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000098","name":"Stem Cell Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003579","name":"University of Toronto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008453","name":"Ontario Institute for Regenerative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.brainres.2023.148648","type":"journal-article","created":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T01:02:03Z","timestamp":1698368523000},"page":"148648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Metformin treatment reduces inflammation, dysmyelination and disease severity in a mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis"],"prefix":"10.1016","volume":"1822","author":[{"given":"Emily A.B.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1032-4338","authenticated-orcid":false,"given":"Jessica","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio Garcia","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monoleena","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"Kandavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindi M.","family":"Morshead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2023.148648_b0005","doi-asserted-by":"crossref","first-page":"15983","DOI":"10.1073\/pnas.2237050100","article-title":"Migration and differentiation of neural precursor cells can be directed by microglia","volume":"100","author":"Aarum","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2023.148648_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s11658-017-0035-3","article-title":"The regulatory mechanisms of NG2\/CSPG4 expression","volume":"22","author":"Ampofo","year":"2017","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.brainres.2023.148648_b0015","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/s41591-020-0985-2","article-title":"Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin","volume":"26","author":"Ayoub","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2023.148648_b0020","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/ana.20016","article-title":"Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion","volume":"55","author":"Barnett","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0025","doi-asserted-by":"crossref","DOI":"10.3791\/53933-v","article-title":"Induction of experimental autoimmune encephalomyelitis in mice and evaluation of the disease-dependent distribution of immune cells in various tissues","author":"Barthelmes","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.brainres.2023.148648_b0030","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/jnc.13745","article-title":"The oligodendrocyte-specific antibody \u2018CC1\u2019 binds Quaking 7","volume":"139","author":"Bin","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2023.148648_b0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00401-014-1310-2","article-title":"Macrophage subsets and microglia in multiple sclerosis","volume":"128","author":"Bogie","year":"2014","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2023.148648_b0040","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12974-022-02487-x","article-title":"Reduced microglia activation following metformin administration or microglia ablation is sufficient to prevent functional deficits in a mouse model of neonatal stroke","volume":"19","author":"Bourget","year":"2022","journal-title":"J Neuroinflamm"},{"key":"10.1016\/j.brainres.2023.148648_b0045","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2023.148648_b0050","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.stemcr.2015.06.011","article-title":"Activating endogenous neural precursor cells using metformin leads to neural repair and functional recovery in a model of childhood brain injury","volume":"5","author":"Dadwal","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.brainres.2023.148648_b0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1044-7431(03)00210-0","article-title":"NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS","volume":"24","author":"Dawson","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.brainres.2023.148648_b0060","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1523\/JNEUROSCI.3803-11.2012","article-title":"Exogenous leukemia inhibitory factor stimulates oligodendrocyte progenitor cell proliferation and enhances hippocampal remyelination","volume":"32","author":"Deverman","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2023.148648_b0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/bs.irn.2022.06.011","article-title":"Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD)","volume":"164","author":"Diem","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.brainres.2023.148648_b0075","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-319-47861-6_7","article-title":"Role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis","volume":"958","author":"Dulamea","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.brainres.2023.148648_b0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3389\/fneur.2020.00784","article-title":"Multiple sclerosis as a syndrome\u2014implications for future management","volume":"11","author":"Dwyer","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0085","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.3390\/ijms21175957","article-title":"Metformin as a potential agent in the treatment of multiple sclerosis","volume":"21","author":"Dziedzic","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.brainres.2023.148648_b0090","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.stemcr.2015.10.014","article-title":"Metformin acts on two different molecular pathways to enhance adult neural precursor proliferation\/self-renewal and differentiation","volume":"5","author":"Fatt","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.brainres.2023.148648_b0095","article-title":"Multiple sclerosis immunology: a foundation for current and future treatments","volume":"269\u2013293","author":"Fitzgerald","year":"2013","journal-title":"Springer."},{"key":"10.1016\/j.brainres.2023.148648_b0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2011.08.002","article-title":"The diagnostic criteria for multiple sclerosis: From Charcot to McDonald","volume":"1","author":"Gafson","year":"2012","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.brainres.2023.148648_b0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jneuroim.2009.10.015","article-title":"Role of the innate immune system in the pathogenesis of multiple sclerosis","volume":"221","author":"Gandhi","year":"2010","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.brainres.2023.148648_b0115","first-page":"1","article-title":"Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J."},{"key":"10.1016\/j.brainres.2023.148648_b0120","doi-asserted-by":"crossref","unstructured":"Gilbert, E.A.B., Livingston, J., Garcia-Flores, E., Kehtari, T., Morshead, C.M., 2023. Metformin improves functional outcomes, activates neural precursor cells and modulates microglia in a sex-dependent manner after spinal cord injury. Stem Cells Trans. Med. May 20;szad030. doi: 10.1093\/stcltm\/szad030.","DOI":"10.1093\/stcltm\/szad030"},{"key":"10.1016\/j.brainres.2023.148648_b0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fncel.2014.00073","article-title":"Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned","volume":"8","author":"Gudi","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.brainres.2023.148648_b0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fimmu.2020.00374","article-title":"Microglia in multiple sclerosis: friend or foe?","volume":"11","author":"Guerrero","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2023.148648_b0135","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12883-021-02344-z","article-title":"The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey","volume":"21","author":"Gustavsen","year":"2021","journal-title":"BMC Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0140","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/awv398","article-title":"The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain","volume":"139","author":"Haider","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2023.148648_b0145","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1756285613488434","article-title":"Sex and gender issues in multiple sclerosis","volume":"6","author":"Harbo","year":"2013","journal-title":"Ther. Adv. Neurol. Diso."},{"key":"10.1016\/j.brainres.2023.148648_b0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fneur.2015.00257","article-title":"Remyelination therapy in multiple sclerosis","volume":"6","author":"Harlow","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/B978-012648860-9\/50007-8","article-title":"Myelination, Dysmyelination, and Demyelination","volume":"87\u2013115","author":"Harry","year":"1998","journal-title":"Handbook of Developmental Neurotoxicology"},{"key":"10.1016\/j.brainres.2023.148648_b0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm1177","article-title":"Experimental autoimmune encephalomyelitis repressed by microglial paralysis","volume":"11","author":"Heppner","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.brainres.2023.148648_b0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7224\/1537-2073.2012-053","article-title":"Natural history of multiple sclerosis symptoms","volume":"15","author":"Kister","year":"2013","journal-title":"Int. J. Ms. Care"},{"key":"10.1016\/j.brainres.2023.148648_b0170","doi-asserted-by":"crossref","first-page":"9590","DOI":"10.1523\/JNEUROSCI.3699-13.2014","article-title":"N-cadherin promotes recruitment and migration of neural progenitor cells from the SVZ neural stem cell niche into demyelinated lesions","volume":"34","author":"Klingener","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2023.148648_b0175","article-title":"Risks and risk management in modern multiple sclerosis immunotherapeutic treatment","volume":"12","author":"Klotz","year":"2019","journal-title":"Ther. Adv. Neurol. Diso"},{"key":"10.1016\/j.brainres.2023.148648_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113454","article-title":"Metformin promotes CNS remyelination and improves social interaction following focal demyelination through CBP Ser436 phosphorylation","volume":"334","author":"Kosaraju","year":"2020","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10735-019-09824-0","article-title":"Oligoprotective effect of metformin through the AMPK-dependent on restoration of mitochondrial hemostasis in the cuprizone-induced multiple sclerosis model","volume":"50","author":"Largani","year":"2019","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.brainres.2023.148648_b0190","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0195","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/cns.13266","article-title":"Heterogeneity of microglia and their differential roles in white matter pathology","volume":"25","author":"Lee","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.brainres.2023.148648_b0200","article-title":"Subacute metformin treatment reduces inflammation and improves functional outcome following neonatal hypoxia ischemia","volume":"7","author":"Livingston","year":"2020","journal-title":"Brain Behav. Immun. - Health"},{"key":"10.1016\/j.brainres.2023.148648_b0205","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00285-016-1087-0","article-title":"Demyelination patterns in a mathematical model of multiple sclerosis","volume":"75","author":"Lombardo","year":"2017","journal-title":"J. Math. Biol."},{"key":"10.1016\/j.brainres.2023.148648_b0210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/14796708.4.2.149","article-title":"Increased soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis and CNS inflammation","volume":"4","author":"Lvarez-Cermeo","year":"2009","journal-title":"Future Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/glia.20755","article-title":"NG2 cell response in the CNP-EGFP mouse after contusive spinal cord injury","volume":"57","author":"Lytle","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2023.148648_b0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","article-title":"Pathological mechanisms in progressive multiple sclerosis","volume":"14","author":"Mahad","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2015.02.003","article-title":"The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis","volume":"127","author":"Mallucci","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2023.148648_b0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2202-13-12","article-title":"Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis","volume":"13","author":"Massella","year":"2012","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.brainres.2023.148648_b0240","doi-asserted-by":"crossref","first-page":"1059833","DOI":"10.3389\/fimmu.2022.1059833","article-title":"Effects of biological sex and pregnancy in experimental autoimmune encephalomyelitis: It\u2019s complicated","volume":"13","author":"McCombe","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2023.148648_b0245","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.brainres.2023.148648_b0250","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/j.pain.0000000000001465","article-title":"Voluntary wheel running reveals sex-specific nociceptive factors in murine experimental autoimmune encephalomyelitis","volume":"160","author":"Mifflin","year":"2019","journal-title":"Pain"},{"key":"10.1016\/j.brainres.2023.148648_b0255","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/1352458510379243","article-title":"Altered M1\/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration","volume":"17","author":"Mikita","year":"2010","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.brainres.2023.148648_b0260","doi-asserted-by":"crossref","first-page":"8005","DOI":"10.4049\/jimmunol.0803563","article-title":"Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis","volume":"182","author":"Nath","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.brainres.2023.148648_b0265","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.stem.2019.08.015","article-title":"Metformin restores CNS remyelination capacity by rejuvenating aged stem cells","volume":"25","author":"Neumann","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.brainres.2023.148648_b0270","doi-asserted-by":"crossref","unstructured":"O\u2019Loughlin, E., Jacob, B., Zeballos, G., Manfre, P., McCullough, A., Gatto, N.T., et al. (2020). C57BL6 mouse substrains demonstrate differences in susceptibility to the demyelinating effects of Cuprizone toxin. Biorxiv, 2020.12.17.423334. doi: 10.1101\/2020.12.17.423334.","DOI":"10.1101\/2020.12.17.423334"},{"issue":"3","key":"10.1016\/j.brainres.2023.148648_bib376","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neures.2013.01.009","article-title":"Three-dimensional ultra-structures of myelin and the axons in the spinal cord: application of SEM with the osmium maceration method to the central nervous system in two mouse models","volume":"75","author":"Nomura","year":"2013","journal-title":"Neurosci Res. Mar"},{"key":"10.1016\/j.brainres.2023.148648_b0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0165-2478(01)00339-X","article-title":"Gender does not influence the susceptibility of C57BL\/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein","volume":"81","author":"Okuda","year":"2002","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.brainres.2023.148648_b0280","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9899.1000149","article-title":"Combinatorial effect of metformin and lovastatin impedes T-cell autoimmunity and neurodegeneration in experimental autoimmune encephalomyelitis","volume":"4","author":"Paintlia","year":"2013","journal-title":"J. Clin. Cell Immunol."},{"key":"10.1016\/j.brainres.2023.148648_b0285","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2004.01.018","article-title":"Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains","volume":"150","author":"Papenfuss","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2023.148648_b0290","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jneumeth.2007.03.013","article-title":"A model of experimental autoimmune encephalomyelitis (EAE) in C57BL\/6 mice for the characterisation of intervention therapies","volume":"163","author":"Peiris","year":"2007","journal-title":"J. Neurosci. Meth."},{"key":"10.1016\/j.brainres.2023.148648_b0295","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","article-title":"Microglial physiology: unique stimuli, specialized responses","volume":"27","author":"Ransohoff","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.brainres.2023.148648_b0300","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/ana.22299","article-title":"Reversible neural stem cell niche dysfunction in a model of multiple sclerosis","volume":"69","author":"Rasmussen","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0305","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1177\/1352458518799580","article-title":"Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry","volume":"25","author":"Rommer","year":"2018","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.brainres.2023.148648_b0310","doi-asserted-by":"crossref","first-page":"eaax1912","DOI":"10.1126\/sciadv.aax1912","article-title":"Age- and sex-dependent effects of metformin on neural precursor cells and cognitive recovery in a model of neonatal stroke","volume":"5","author":"Ruddy","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.brainres.2023.148648_b0315","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nature14957","article-title":"Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination","volume":"526","author":"Samanta","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2023.148648_b0320","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00737283","article-title":"The intermediate filament cytoskeleton of myofibroblasts: An immunofluorescence and ultrastructural study","volume":"403","author":"Sch\u00fcrch","year":"1984","journal-title":"Virchows Archiv A"},{"key":"10.1016\/j.brainres.2023.148648_b0325","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mrm.20774","article-title":"Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum","volume":"55","author":"Sun","year":"2006","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.brainres.2023.148648_b0330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.brainresbull.2018.04.008","article-title":"Neuroprotective effects of metformin on traumatic brain injury in rats associated with NF-\u03baB and MAPK signaling pathway","volume":"140","author":"Tao","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.brainres.2023.148648_b0335","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/jnr.22335","article-title":"Attenuation of proliferation in oligodendrocyte precursor cells by activated microglia","volume":"88","author":"Taylor","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2023.148648_b0340","doi-asserted-by":"crossref","first-page":"e25406","DOI":"10.1371\/journal.pone.0025406","article-title":"Chemokines and inflammatory mediators interact to regulate adult murine neural precursor cell proliferation, survival and differentiation.","volume":"6","author":"Turbic","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.brainres.2023.148648_b0345","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.3389\/fimmu.2018.01236","article-title":"Metformin and autoimmunity: a \u201cnew deal\u201d of an old drug","volume":"9","author":"Ursini","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2023.148648_b0350","doi-asserted-by":"crossref","unstructured":"Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R. A., et al. (2020). Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition. Mult Scler J 26, 1816\u20131821. doi: 10.1177\/1352458520970841.","DOI":"10.1177\/1352458520970841"},{"key":"10.1016\/j.brainres.2023.148648_b0355","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2012.03.016","article-title":"Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation","volume":"11","author":"Wang","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.brainres.2023.148648_b0360","first-page":"4113","article-title":"Necrostatin-1 ameliorates the pathogenesis of experimental autoimmune encephalomyelitis by suppressing apoptosis and necroptosis of oligodendrocyte precursor cells","volume":"18","author":"Wang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.brainres.2023.148648_b0365","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.724718","article-title":"Progress in the application of drugs for the treatment of multiple sclerosis","volume":"12","author":"Wei","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.brainres.2023.148648_b0370","article-title":"An alternative cuprizone-induced demyelination and remyelination mouse model","volume":"9","author":"Zhen","year":"2017","journal-title":"ASN Neurol."},{"key":"10.1016\/j.brainres.2023.148648_b0375","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of \u2018homeostatic\u2019 microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899323004195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899323004195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T18:23:49Z","timestamp":1736360629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899323004195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":74,"alternative-id":["S0006899323004195"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2023.148648","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin treatment reduces inflammation, dysmyelination and disease severity in a mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2023.148648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"148648"}}